June | 2025
Acandis Supports ICARUS Study Advancing Treatment for Stroke Patients with ICAD-Related LVO.
Acandis is proud to be listed as a collaborator in the important investigator-initiated ICARUS, which is being conducted by the University Hospital Basel under the direction of Prof. Dr. Marios Nikos Psychogios. The aim of the study is to evaluate new treatment options for stroke patients with large vessel occlusion (LVO) due to intracranial atherosclerosis (ICAD) when standard therapy is not successful.
The ICARUS study compares early intracranial stent implantation with the continuation of conventional therapy and will be conducted at several European centers with a total of 498 patients.
“With our CREDO® heal stent and NeuroSpeed® PTA balloon catheter, we are proud to contribute technologies that meet the procedural demands of ICAD-related interventions. This study has the potential to help establish new treatment guidelines—offering more patients access to life-saving therapies,” says Dr. Andreas Schüßler, CEO of Acandis.
You can access the full press release here.